SubsidieMeestersThe Holy Grail in Bone regeneration
GreenBone aims to revolutionize bone grafts with a synthetic Rattan wood-based implant that mimics natural bone, enhancing regeneration and targeting the spinal market by 2025.
Projectdetails
Introduction
Regeneration of large bone defects is an unmet medical need with a high socio-economic burden, affecting millions of people worldwide.
Innovation
To overcome the limitations of existing solutions for bone replacement, we developed GreenBone, our pioneering acellular synthetic bone graft obtained from a proprietary biomorphic transformation process of Rattan wood.
Features
By mimicking the chemical composition and 3D pore structure of natural human bone, we are able to provide an optimum microenvironment capable of driving:
- Inductive bone performance
- De-novo bone mineralisation response at the ectopic site
Market Strategy
With the EIC accelerator grant, we aim to disrupt the bone graft market by introducing the first technologically advanced spinal implant that combines the needed mechanical strength with enhanced regenerative capacity.
Goals
We aim to bring our product to the spinal market segment in 2025, with the following targets:
- Reach 10% market share by 2030
- Grow our company team to more than 40 skilled professionals
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.458.128 |
| Totale projectbegroting | € 3.511.612 |
Tijdlijn
| Startdatum | 1-9-2022 |
| Einddatum | 31-8-2025 |
| Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- GREENBONE ORTHO SPApenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Drug solution for bone fracture nonunionsGenera Research aims to develop OSTEOGROW-C, a novel biological drug using patients' blood to treat bone fracture nonunion, promising effective regeneration and reduced complications. | EIC Accelerator | € 2.499.999 | 2025 | Details |
SmartFuse: Game-changer to create a new gold-standard for spinal fusion surgery with wirelessly technologyThe project aims to enhance spinal fusion surgery outcomes by integrating a wireless bio-electrical stimulation system into implants to accelerate bone growth and provide real-time healing feedback. | EIC Accelerator | € 2.500.000 | 2022 | Details |
A novel non-invasive therapy based on injectable viscous gel for restoring the natural biomechanics of the spine and relieving patients from painNC Biomatrix's VitaDisc is a revolutionary non-invasive injectable biomatrix that restores disc function and height, addressing disc degeneration and offering a scalable solution for orthopedic treatments. | EIC Accelerator | € 2.499.999 | 2023 | Details |
Drug solution for bone fracture nonunions
Genera Research aims to develop OSTEOGROW-C, a novel biological drug using patients' blood to treat bone fracture nonunion, promising effective regeneration and reduced complications.
SmartFuse: Game-changer to create a new gold-standard for spinal fusion surgery with wirelessly technology
The project aims to enhance spinal fusion surgery outcomes by integrating a wireless bio-electrical stimulation system into implants to accelerate bone growth and provide real-time healing feedback.
A novel non-invasive therapy based on injectable viscous gel for restoring the natural biomechanics of the spine and relieving patients from pain
NC Biomatrix's VitaDisc is a revolutionary non-invasive injectable biomatrix that restores disc function and height, addressing disc degeneration and offering a scalable solution for orthopedic treatments.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
A 3D-printable biomimetic bone regeneration materialPRIOBONE aims to validate a novel 3D-printable, bone-mimetic material for critical-size bone defects, offering a customizable, cost-effective solution to improve healing outcomes. | ERC Proof of... | € 150.000 | 2024 | Details |
Self-feeding implants to improve and accelerate tissue healing using nutritional nanoparticlesThe NutriBone project aims to develop a patented self-feeding bone implant that enhances long-term viability and reduces failure rates for large bone defects through glycogen-based glucose release. | ERC Proof of... | € 150.000 | 2024 | Details |
Ontwikkelen nieuw middel voor de lokale genezing van botbreukenDit project ontwikkelt een nieuwe formulering van microspheres met groeifactoren voor Demineralized Bone Material (DBM) om de effectiviteit bij moeilijk genezende botbreuken te verbeteren. | Mkb-innovati... | € 194.500 | 2015 | Details |
BioBone: Bioactive Hydrogel-based Implants to Induce Bone RegenerationThe project aims to enhance bone regeneration after tumor resection by developing 3D-printed porous titanium implants integrated with bioactive materials, improving patient outcomes and reducing complications. | ERC Proof of... | € 150.000 | 2024 | Details |
AIM+; De ontwikkeling van een poreus, titanium implantaat voor wervelfracturenHet project ontwikkelt een innovatief, 3D-geprint titanium implantaat voor wervelfracturen dat botgroei bevordert en complicaties van traditionele behandelingen vermindert. | Mkb-innovati... | € 162.175 | 2019 | Details |
A 3D-printable biomimetic bone regeneration material
PRIOBONE aims to validate a novel 3D-printable, bone-mimetic material for critical-size bone defects, offering a customizable, cost-effective solution to improve healing outcomes.
Self-feeding implants to improve and accelerate tissue healing using nutritional nanoparticles
The NutriBone project aims to develop a patented self-feeding bone implant that enhances long-term viability and reduces failure rates for large bone defects through glycogen-based glucose release.
Ontwikkelen nieuw middel voor de lokale genezing van botbreuken
Dit project ontwikkelt een nieuwe formulering van microspheres met groeifactoren voor Demineralized Bone Material (DBM) om de effectiviteit bij moeilijk genezende botbreuken te verbeteren.
BioBone: Bioactive Hydrogel-based Implants to Induce Bone Regeneration
The project aims to enhance bone regeneration after tumor resection by developing 3D-printed porous titanium implants integrated with bioactive materials, improving patient outcomes and reducing complications.
AIM+; De ontwikkeling van een poreus, titanium implantaat voor wervelfracturen
Het project ontwikkelt een innovatief, 3D-geprint titanium implantaat voor wervelfracturen dat botgroei bevordert en complicaties van traditionele behandelingen vermindert.